The Facts About Glutathione and Parkinson's Disease

Written by Priya Shah


Copyright © 2004 Priya Shah

Parkinson's Disease (PD), a devastating illness, occurs in one of every 100 people over 65.

It is a slowly progressing disease ofrepparttar nervous system that results in progressive destruction of brain cells (neurons) in an area ofrepparttar 115346 brain calledrepparttar 115347 substantia nigra. Death occurs usually as a result of secondary complications such as infection.

One ofrepparttar 115348 mechanisms known to destroy neurons is damage by free radicals or reactive oxygen species - destructive molecules produced by oxidation ofrepparttar 115349 neurotransmitter dopamine.

The Role of Dopamine

The cells ofrepparttar 115350 substantia nigra use dopamine - a chemical messenger between brain or nerve cells - to communicate with cells in another region ofrepparttar 115351 brain calledrepparttar 115352 striatum.

When nigral cells are lost, nigral dopamine levels fall, resulting in a decrease in striatal dopamine.

The typical symptoms of PD - motor function deficiencies characterized by muscle rigidity, jerky movements, rhythmic resting tremors - arerepparttar 115353 result of low levels of striatal dopamine.

Most dopaminergic drugs used to treat PD, are aimed at temporarily replenishing or mimicking dopamine. They improve some symptoms, but do not restore normal brain function nor halt brain cell destruction.

Dopaminergic drugs are generally effective at first in reducing many PD symptoms, but over time they lose their effect.

They also cause severe side effects because they overstimulate nerve cells elsewhere inrepparttar 115354 body and cause confusion, hallucinations, nausea and fluctuations inrepparttar 115355 movement of limbs.

The Role of Antioxidants

When dopaminergic neurons are lost inrepparttar 115356 course of Parkinson's disease,repparttar 115357 metabolism of dopamine is increased - which in turn increasesrepparttar 115358 formation of highly neurotoxic hydroxyl radicals.

The most important free radical scavenger inrepparttar 115359 cells ofrepparttar 115360 substantia nigra isrepparttar 115361 powerful brain antioxidant, glutathione. Glutathione levels in PD patients are low.

And as we age, levels of glutathione inrepparttar 115362 dopaminergic neurons ofrepparttar 115363 substantia nigra decreases. This appears to hasten cell death and advancerepparttar 115364 progression of PD.

At least 80 percent ofrepparttar 115365 substantia nigra cells are lost before symptoms of Parkinson's disease become apparent. This is why it becomes essential to protect or maintain these cells under oxidative stress.

How does Glutathione help in Parkinson's Disease?

Several factors explain why glutathione is so beneficial in Parkinson’s disease.

1. Glutathione increasesrepparttar 115366 sensitivity ofrepparttar 115367 brain to dopamine. So although glutathione doesn't raise dopamine levels, it allowsrepparttar 115368 dopamine inrepparttar 115369 brain to be more effective.

2. Glutathione's powerful antioxidant activity protectsrepparttar 115370 brain from free radical damage.

Why Are Europeans Thinner?

Written by Bantadiet.com


Every American tourist that returned from Europe admits that Europeans are much thinner than Americans.

Michael Fumento wrote in his book "The Fat ofrepparttar Land" thatrepparttar 115345 average North American is more than 16 pounds heavier thanrepparttar 115346 average Northern European and thatrepparttar 115347 US has almost three times as many grossly obese people as Sweden. "Yet by our [American] standards they are doing everything wrong," he added.

Let's look at some statistical data.

Obesity(*) Trends

Europe 1961 7 % USA 1961 13 %

Sweden 1988/89 5.3 to 9.1 USA 1988/89 32 to 33.5

Europe Currently 21.0 to 20.8 USA Currently 64 to 62

How could it be? The latest conclusion: Europeans serve smaller portions inrepparttar 115348 restaurants -- so,repparttar 115349 dietitians concluded, such isrepparttar 115350 Europeans' habit.

Cont'd on page 2 ==>
 
ImproveHomeLife.com © 2005
Terms of Use